ArticleJournal of surgical case reports2025
Porto-spleno-mesenteric thrombosis secondary to medroxyprogesterone acetate as a treatment for abnormal uterine bleeding: a case report.
Article in Journal of surgical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute mesenteric venous thrombosis is a rare and potentially lethal cause of intestinal ischemia. We report a 38-year-old woman with abnormal uterine bleeding, with anemia, and prolonged use of medroxyprogesterone acetate. She presented severe abdominal pain, peritoneal signs, and systemic inflammatory response. Computed tomography revealed thrombosis of the portal, splenic, and superior mesenteric veins with jejunal wall thickening. Initial laparotomy showed a viable bowel; full anticoagulation was started. She later developed perforation requiring jejunal resection and subsequent reoperation for anastomotic dehiscence. Extensive workup revealed no prothrombotic disorder other than progestin use. This case highlights the need to consider hormonal agents as potential triggers of porto-spleno-mesenteric thrombosis, even in young women without comorbidities, and to pursue multidisciplinary, individualized management to balance timely surgery with preservation of bowel length.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.